Abstract
Mutations in the dedicator of cytokinesis 8 (DOCK8) gene cause a combined immunodeficiency usually diagnosed as autosomal recessive hyper IgE syndrome. We sought to reveal the varying manifestations in patients with a unique mutation in DOCK8 gene by a retrospective medical record review. Ten patients from five consanguineous families and three tribes were included. Seven patients were homozygous for the c.C5134A, p.S1711X mutation, and the remaining three patients were their siblings manifesting hyper IgE syndrome features without a genetic diagnosis. Prior to the genetic diagnosis, the clinical diagnosis was “hyper IgE syndrome” in six patients and “anti-pneumococcal antibody deficiency,” “recurrent pneumonia with bronchiectasis,” and “asthma with hypereosinophilic syndrome” each diagnosed once. One additional patient was diagnosed due to family history. The age of presentation varied from 1 to 16 months. Eczema was diagnosed in all patients, food allergies in three, and severe herpes keratitis or malignancy or autoimmunity in two patients. Elevated IgE was recorded in nine patients; however, in six patients, the initial serum IgE concentration was equal to or less than three times the normal concentration for age, and in these patients, the median age at IgE evaluation was 7.5 months compared with 21.5 months in patients with an initial IgE concentration above three times the normal concentration for age (P = 0.067). The spectrum of disease manifestations in patients with a unique mutation in DOCK8 is variable. The genotype-phenotype correlations may be modified by genetic and/or epigenetic modifiers beyond the monogenic effect. Younger patients tend to have lower IgE concentrations at the initial measurement of IgE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zhang Q et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046–55.
Engelhardt KR et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289–302.e4.
Aydin SE et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options—a review of 136 patients. J Clin Immunol. 2015;35:189–98. doi:10.1007/s10875-014-0126-0.
Zhang Q et al. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers. 2010;29:131–9.
Crawford G et al. DOCK8 is critical for the survival and function of NKT cells. Blood. 2013;122(12):2052–61.
aan de Kerk DJ et al. Aberrant humoral immune reactivity in DOCK8 deficiency with follicular hyperplasia and nodal plasmacytosis. Clin Immunol. 2013;149:25–31. doi:10.1016/j.clim.2013.06.002.
Ham H et al. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J Immunol. 2013;190:3661–9.
Mizesko MC et al. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2013;131:840–8.
Harada Y et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood. 2012;119:4451–61.
Jabara HH et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol. 2012;13:612–20.
Jing H et al. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype. J Allergy Clin Immunol. 2014;133:1667–75.
Alsum Z et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol. 2013;33:55–67.
Al-Herz W et al. Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait. Clin Immunol. 2012;143:266–72.
Lek M et al. Exome aggregation consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.
Pai SY et al. Flow cytometry diagnosis of dedicator of cytokinesis 8 (DOCK8) deficiency. J Allergy Clin Immunol. 2014;134:221–3. doi:10.1016/j.jaci.2014.02.023.
Randall KL et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305–20.
Mahnke YD et al. The who’s who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol. 2013;43:2797–809.
Chou J et al. A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome. J Allergy Clin Immunol. 2012;130:1414–6.
Wolach O et al. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients. J Clin Immunol. 2014;34:163–70.
Engelhardt KR et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015;136:402–12.
Ku CL et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007;204:2407–22.
von Bernuth H et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science. 2008;321:691–6.
Schutze GE et al. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J. 2002;21:278–82.
Wood PM et al. A mutation in Bruton’s tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency. J Pediatr. 2001;139:148–51.
Gaschignard J et al. Invasive pneumococcal disease in children can reveal a primary immunodeficiency. Clin Infect Dis. 2014;59:244–51. doi:10.1093/cid/ciu274.
Jouhadi Z et al. Ten-year follow-up of a DOCK8-deficient child with features of systemic lupus erythematosus. Pediatrics. 2014;134:e1458–63.
Janssen E et al. Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. J Allergy Clin Immunol. 2014;134:1365–74. doi:10.1016/j.jaci.2014.07.042.
Na’amnih W et al. Prevalence of consanguineous marriages and associated factors among Israeli Bedouins. J Community Genet. 2014;5:395–8. doi:10.1007/s12687-014-0188-y.
Zhang Q, Jing H, Su HC. Recent advances in DOCK8 immunodeficiency syndrome. J Clin Immunol. 2016;36:441–9. doi:10.1007/s10875-016-0296-z.
Shearer WT et al. Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973–80.
Piątosa B et al. B cell subsets in healthy children: reference values for evaluation of B cell maturation process in peripheral blood. Cytometry B Clin Cytom. 2010;78:372–81. doi:10.1002/cyto.b.20536.
Acknowledgments
The authors are indebted to Mrs. I. Dulman and Mrs. T. Gershberg for excellent technical assistance. The work performed by GS was partially supported by the Israeli Ministry of Immigrant Absorption.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study and collection of these data were approved by the Soroka University Medical Center ethical committee.
Rights and permissions
About this article
Cite this article
Broides, A., Mandola, A.B., Levy, J. et al. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation. Immunol Res 65, 651–657 (2017). https://doi.org/10.1007/s12026-016-8883-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-016-8883-x